BDKRB2 and neoplasm: Moreover, in vitro and in vivo assays showed that NMI significantly promoted tumor proliferation, invasion, and metastasis of HCC by inducing its downstream target BDKRB2 expression and activator of MAPK/ERK signaling pathway.